15-Deoxy-Δ12,14-Prostaglandin J2 is a ligand for the adipocyte determination factor PPARγ

Boehm, 1994, Synthesis of high specific activity [3H]-9-cis-retinoic acid and its application for identifying retinoids with unusual binding properties, J. Med. Chem., 37, 408, 10.1021/jm00029a013

Burns, 1994, Modulation of gene expression by calreticulin binding to the glucocorticoid receptor, Nature, 367, 476, 10.1038/367476a0

Campfield, 1995, Recombinant mouse Ob protein: evidence for a peripheral signal linking adiposity and central neural networks, Science, 269, 546, 10.1126/science.7624778

Cantello, 1994, ([σ(Heterocyclylamino)alkoxy]benzyl)-2,4- thiazolidinediones as potent anti hyperglycemic agents, J. Med. Chem., 37, 3977, 10.1021/jm00049a017

Chawla, 1994, Peroxisome proliferator-activated receptor (PPAR)γ: adiposepredominant expression and induction early in adipocyte differentiation, Endocrinology, 135, 798, 10.1210/endo.135.2.8033830

Dedhar, 1994, Inhibition of nuclear hormone receptor activity by calreticulin, Nature, 367, 480, 10.1038/367480a0

Evans, 1988, The steroid and thyroid hormone receptor superfamily, Science, 240, 889, 10.1126/science.3283939

Feinstein, 1993, Tumor necrosis factor-a suppresses insulin-induced tyrosine phosphorylation of insulin receptor and its substrates, J. Biol. Chem., 268, 26055, 10.1016/S0021-9258(19)74276-8

Fitzpatrick, 1983, Albumin-catalyzed metabolism of prostaglandin D2. Identification of products formed in vitro, J. Biol. Chem., 258, 11713, 10.1016/S0021-9258(17)44287-6

Flier, 1995, The adipocyte: storage depot or node on the energy information superhighway?, Cell, 80, 15, 10.1016/0092-8674(95)90445-X

Forman, 1990, Interactions among a subfamily of nuclear hormone receptors: the regulatory zipper model, Mol. Endocrinol., 4, 1293, 10.1210/mend-4-9-1293

Forman, 1991, pEXPRESS: a family of expression vectors containing a single transcription unit active in prokaryotes, eukaryotes and in vitro, Gene, 105, 9, 10.1016/0378-1119(91)90507-8

Forman, 1995, Identification of a nuclear receptor that is activated by farnesol metabolites, Cell, 81, 687, 10.1016/0092-8674(95)90530-8

Forman, 1995, Unique esponse pathways are established by allosteric interactions among nuclear hormone receptors, Cell, 81, 541, 10.1016/0092-8674(95)90075-6

Foxworthy, 1988, Inhibition of hepatic fatty acid oxidation at carnitine palmitoyltransferase I by the peroxisome proliferator 2-hydroxy-3-propyl-4-[6-(tetrazol-5-yl) hexyloxy]acetophenone, Biochem. J., 252, 409, 10.1042/bj2520409

Fukushima, 1990, Prostaglandin J2: anti-tumour and anti-viral activities and the mechanisms involved, Eicosanoids, 3, 189

Fukushima, 1992, Biological activities and mechanisms of action of PGJ2 and related compounds: an update, Prostaglandins Leukot. Essent. Fatty Acids, 47, 1, 10.1016/0952-3278(92)90178-L

Gottlicher, 1992, Fatty acids activate a chimera of the clofibric acid-activated receptor and the glucocorticoid receptor, 89, 4653

Grundy, 1990, Metabolic and health complications of obesity, Dis. Mon., 36, 641

Gulick, 1994, The peroxisome proliferator-activated receptor regulates mitochondrial fatty acid oxidative enzyme gene expression, 91, 11012

Halaas, 1995, Weight-reducing effects of the plasma protein encoded by the obese gene, Science, 269, 543, 10.1126/science.7624777

Harris, 1994, Localization of a pioglitazone response element in the adipocyte fatty acid-binding protein gene, Mol. Pharmacol., 45, 439

Heyman, 1992, 9-cis retinoic acid is a high affinity ligand for the retinoid X receptor, Cell, 68, 397, 10.1016/0092-8674(92)90479-V

Hiragun, 1988, Preadipocyte differentiation in vitro: identification of a highly active adipogenic agent, J. Cell Physiol., 134, 124, 10.1002/jcp.1041340115

Hirata, 1988, Occurrence of 9-deoxy-Δ9-Δ12-13,14-dihydroprostaglandin D2 in human urine, J. Biol. Chem., 263, 16619, 10.1016/S0021-9258(18)37435-0

Hofmann, 1994, Altered gene expression for tumor necrosis factor-a and its receptors during drug and dietary modulation of insulin resistance, Endocrinology, 134, 264, 10.1210/endo.134.1.8275942

Hofmann, 1992, New oral thiazolidinedione antidiabetic agents act as insulin sensitizers, Diabetes Care, 15, 1075, 10.2337/diacare.15.8.1075

Hotamisligil, 1993, Adipose expression of tumor necrosis factor-a: direct role in obesity-linked insulin resistance, Science, 259, 87, 10.1126/science.7678183

Hotamisligil, 1994, Reduced tyrosine kinase activity of the insulin receptor in obesity-diabetes: central role of tumor necrosis factor-α, J. Clin. Invest., 94, 1543, 10.1172/JCI117495

Hotamisligil, 1994, Tumor necrosis factor α: a key component of the obesity-diabetes link, Diabetes, 43, 1271, 10.2337/diab.43.11.1271

Hotamisligil, 1995, Increased adipose tissue expression of tumor necrosis factor-α in human obesity and insulin resistance, J. Clin. Invest., 95, 2409, 10.1172/JCI117936

Ibrahimi, 1994, Evidence for a common mechanism of action for fatty acids and thiazolidinedione antidiabetic agents on gene expression in preadipose cells, Mol. Pharmacol., 46, 1070

Issemann, 1990, Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators, Nature, 347, 645, 10.1038/347645a0

Keller, 1993, Fatty acids and retinoids control lipid metabolism through activation of peroxisome proliferator-activated receptor-retinoid X receptor heterodimers, 90, 2160

Kikawa, 1984, 9-Deoxy-Δ9,Δ13-13,14-dihydroprostaglandin D2 a metabolite of prostaglandin D2 formed in human plasma, 81, 1317

Kim, 1993, Prostaglandin A2 and Δ12-prostaglandin J2 induce apoptosis in L1210 cells, FEBS Lett., 321, 209, 10.1016/0014-5793(93)80110-G

Kletzien, 1992, Enhancement of adipocyte differentiation by an insulin-sensitizing agent, Mol. Pharmacol., 41, 393

Kliewer, 1992, Convergence of 9-cis retinoic acid and peroxisome proliferator signalling pathways through heterodimer formation of their receptors, Nature, 358, 771, 10.1038/358771a0

Kliewer, 1994, Differential expression and activation of a family of murine peroxisome proliferator-activated receptors, 91, 7355

Kuczmarski, 1994, Increasing prevalence of overweight among US adults: the national health and nutrition examination surveys, 1960 to 1991, J. Am. Med. Soc., 272, 205

Kurokawa, 1994, Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding, Nature, 371, 528, 10.1038/371528a0

Lehmann, 1995, An antidiabetic thiazolidinedione is a high affinity ligand for peroxisome proliferator-activated receptor γ, J. Biol. Chem., 270, 12953, 10.1074/jbc.270.22.12953

Levin, 1992, 9-cis retinoic acid stereoisomer binds and activates the nuclear receptor RXRα, Nature, 355, 359, 10.1038/355359a0

Mahmud, 1984, On the identification and biological properties of prostaglandin J2, Prostaglandins Leukot. Med., 16, 131, 10.1016/0262-1746(84)90066-0

Mangelsdorf, 1991, A direct repeat in the cellular retinolbinding protein type II gene confers differential regulation by RXR and RAR, Cell, 66, 555, 10.1016/0092-8674(81)90018-0

Marshall, 1987, Leukotriene receptor antagonists. I. Synthesis and structure-activity relationships of alkoxyacetophenone derivatives, J. Med. Chem., 30, 682, 10.1021/jm00387a018

McCall, 1992, Serum tumour necrosis factor a and insulin resistance in gastrointestinal cancer, Br. J. Surg., 79, 1361, 10.1002/bjs.1800791240

McKinney, 1967, An orcein-oil red O stain for concomitant demonstration of elastic tissue and lipid, Stain Technol., 42, 245, 10.3109/10520296709115018

Narumiya, 1995, Structures, properties and distributions of prostanoid receptors, Adv. Prostaglandin Thromboxane Leukot. Res., 23, 17

Narumiya, 1986, Site and mechanism of growth inhibition by prostaglandins. II. Temperature-dependent transfer of a cyclopentenone prostaglandin to nuclei, J. Pharmacol. Exp. Ther., 239, 506

Narumiya, 1987, Site and mechanism of growth inhibition by prostaglandins. III. Distribution and binding of prostaglandin A2 and Δ12-prostaglandin J2 in nuclei, J. Pharmacol. Exp. Ther., 242, 306

Nolan, 1994, Improvement in glucose tolerance and insulin resistance in obese subjects treated with troglitazone, N. Engl. J. Med., 331, 1188, 10.1056/NEJM199411033311803

Ohsumi, 1994, Troglitazone prevents the inhibitory effects of inflammatory cytokines on insulininduced adipocyte differentiation in 3T3-L1 cells, Endocrinology, 135, 2279, 10.1210/endo.135.5.7956951

O'Malley, 1989, Did eucaryotic steroid receptors evolve from intracrine gene regulators?, Endocrinology, 125, 1119, 10.1210/endo-125-3-1119

Palmer, 1995, Novel sequence determinants in peroxisome proliferator signaling, J. Biol. Chem., 270, 16114, 10.1074/jbc.270.27.16114

Pelleymounter, 1995, Effects of the obese gene product on body weight regulation in Ob/Ob mice, Science, 269, 540, 10.1126/science.7624776

Sadowski, 1989, A vector for expressing GAL4 (1–147) fusions in mammalian cells, Nucl. Acids Res., 17, 7539, 10.1093/nar/17.18.7539

Sandouk, 1993, Antidiabetic agent pioglitazone enhances adipocyte differentiation of 3T3-F442A cells, Am. J. Physiol., 264, C1600, 10.1152/ajpcell.1993.264.6.C1600

Schulman, 1995, Interactions between retinoid X receptor and a conserved region of the TATA-binding protein mediate hormone-dependent transactivation, 92, 8288

Smith, 1991, Prostaglandin and thromboxane biosynthesis, Pharmacol. Ther., 49, 153, 10.1016/0163-7258(91)90054-P

Sohda, 1990, Studies on antidiabetic agents. Synthesis and hypoglycemic activity of 5-]4-(pyridylalkoxy)benzyl]-2,4-thiazolidinediones, Arzneimittelforschung, 40, 37

Szalkowski, 1995, Antidiabetic thiazolidinediones block the inhibitory effect of tumor necrosis factor-a on differentiation, insulin-stimulated glucose uptake, and gene expression in 3T3-L1 cells, Endocrinology, 136, 1474, 10.1210/endo.136.4.7895657

Tontonoz, 1994, Adipocytespecific transcription factor ARF6 is a heterodimeric complex of two nuclear hormone receptors, PPARγ and RXRα, Nucl. Acids Res., 22, 5628, 10.1093/nar/22.25.5628

Tontonoz, 1994, mPPARγ2: tissue-specific regulator of an adipocyte enhancer, Genes Dev., 8, 1224, 10.1101/gad.8.10.1224

Tontonoz, 1994, Stimulation of adipogenesis in fibroblasts by PPARγ2, a lipid-activated transcription factor, Cell, 79, 1147, 10.1016/0092-8674(94)90006-X

Yao, 1993, Functional ecdysone receptor is the product of EcR and Ultraspiracle genes, Nature, 366, 476, 10.1038/366476a0